(OTC: HRAL), (OTCBB: DNAG), (OTCBB: NNPP).

RealPennies.com: Turning Pennies into dollars: (OTC: HRAL), (OTCBB: DNAG), (OTCBB: NNPP).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://hral.realpennies.com

HearAtLast Holdings, Inc. (OTC: HRAL)February 4, 2008) rapid expansion should have investors closely monitoring the stock closely. Early this morning, the company issued a press release announcing that that it has received another license from Wal-Mart Canada (NYSE: WMT) to open its 18th hearing-aid clinic which will be co-located within Wal-Mart Store #5778 located at 135 First Commerce Dr, Aurora, Ontario.

Great news from HRAL, as the store grand opening is scheduled for Tuesday, February the 5th, 2008. The Company currently owns and operates 17 hearing clinics co-located in Wal-Mart Stores, Wal-Mart Supercenters, and Sam's Clubs in Canada and one clinic in the U.S. in The Villages, Florida.

This expansion is a direct result of the Company exercising its option under a master licensing agreement with Wal-Mart Canada Corp., which allows HearAtLast to open hearing aid clinics within numerous Wal-Mart Stores, Wal-Mart Supercenters, and Sam's Club's throughout Canada.

"We are pleased to be opening our new clinic in the Town of Aurora," stated Mr. Robert J. Oswald, President of HearAtLast Holdings Inc. "Aurora has a key demographic for us with a large presence from both the automotive and insurance industries. With our continued expansion in Ontario, Alberta, and recently the U.S. market, our brand is thriving and there continues to be great new opportunities for our company."

HearAtLast Holdings, Inc. owns and operates its wholly-owned subsidiary HearAtLast Inc., a chain of hearing stores specializing in the sale of digital hearing aids and testing services. The company develops, owns, and operates hearing aid clinics co-located within select Wal-Mart stores throughout Canada. HearAtLast facilities sell a selection of high quality brand name hearing aids and also offer complimentary screening tests, clinical hearing tests, instant custom MP3 headphones and custom hearing protection. The Company's mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.

For more info: http://dnag.realpennies.com

DNAPrint Genomics, Inc. (OTCBB: DNAG) has developed, patented and published various technologies for an improved, 21st century model of clinical product development - aimed at maximizing effectiveness, minimizing unintended effects, reducing costs and shifting the risk to reward ratio during clinical product development. On Feb. 1st 2008, the company was pleased to announce a jointly signed letter of intent to be acquired by Nanobac Pharmaceuticals Inc. With the acquisition, which is subject to DNAPrint Genomics shareholder approval, Nanobac becomes one of a select group of next-generation drug and diagnostics developers, applying advanced computational methods and systematic genome-based approaches to streamline clinical product development. Nanobac adds advanced drug and diagnostics development programs, key patents and patent applications, and a proprietary product modeling platform to its existing initiatives, and expands its focus into multiple disease sites for both Diagnostics and Therapeutics.

For more info: http://nnpp.realpennies.com

Nano-Proprietary, Inc. (OTCBB: NNPP) is a holding company consisting of two wholly owned operating subsidiaries. Applied Nanotech Inc. is a premier research and commercialization organization dedicated to developing applications for nanotechnology with an extremely strong position in the fields of electron emission applications from carbon film/nanotubes, sensors, functionalized nanomaterials, and nanoelectronics.

On Jan. 31st 2008 the company announced that its subsidiary Applied Nanotech, Inc. will exhibit at "nano tech 2008" in Tokyo, Japan February 13 - 15, 2008. For additional information on this conference visit the conference website at http://www.ics-inc.co.jp/nanotech/en/index.html.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com